145 related articles for article (PubMed ID: 9191613)
1. Cost-effectiveness analysis.
Barry HC
J Fam Pract; 1997 Jun; 44(6):524; author reply 524-5. PubMed ID: 9191613
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis.
King DE
J Fam Pract; 1997 Jun; 44(6):524-5. PubMed ID: 9191614
[No Abstract] [Full Text] [Related]
3. Antibiotics: neither cost effective nor 'cough' effective.
Hueston WJ
J Fam Pract; 1997 Mar; 44(3):261-5. PubMed ID: 9071245
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ
Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic prescribing for bronchitis: time for a change?
Trigg CJ; Davies RJ
Respir Med; 1994 Mar; 88(3):161-3. PubMed ID: 8209066
[No Abstract] [Full Text] [Related]
7. Treating acute bronchitis with azithromycin.
Mosby JA
Am Fam Physician; 1997 Feb; 55(2):444, 447-8. PubMed ID: 9054218
[No Abstract] [Full Text] [Related]
8. Antibiotics for acute bronchitis: a meta-analysis.
Chen FM; Church L
J Fam Pract; 1999 Mar; 48(3):171. PubMed ID: 10086754
[No Abstract] [Full Text] [Related]
9. Antibiotics for acute bronchitis.
Lindbaek M
J Fam Pract; 1998 Dec; 47(6):421-2. PubMed ID: 9866664
[No Abstract] [Full Text] [Related]
10. [Antibiotic therapy in bronchial infections. 1: Acute and chronic bronchitis].
Buchenroth M
MMW Fortschr Med; 1999 Dec; 141(48):49-50. PubMed ID: 10728302
[No Abstract] [Full Text] [Related]
11. Bronchitis.
Dunlay J
J Fam Pract; 1993 Sep; 37(3):221. PubMed ID: 8409867
[No Abstract] [Full Text] [Related]
12. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem antibiotics for serious infections.
Hawkey PM; Livermore DM
BMJ; 2012 May; 344():e3236. PubMed ID: 22654063
[No Abstract] [Full Text] [Related]
14. Excessive antibiotic use for acute respiratory infections in the United States.
Gonzales R; Malone DC; Maselli JH; Sande MA
Clin Infect Dis; 2001 Sep; 33(6):757-62. PubMed ID: 11512079
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic pharmacoeconomics].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2008 Nov; 25(149):437-8. PubMed ID: 19177784
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacoeconomics of infection in the intensive care unit].
Grau S; Alvarez-Lerma F
Rev Esp Quimioter; 2008; 21 Spec No 1():26-34. PubMed ID: 18752077
[TBL] [Abstract][Full Text] [Related]
17. Use of antibiotics in patients with acute bronchitis.
Seehusen DA
Am Fam Physician; 1998 Oct; 58(6):1303. PubMed ID: 9803190
[No Abstract] [Full Text] [Related]
18. [The other side of the coin: socioeconomic analysis of antibiotic resistance].
García-Altés A; Jovell AJ; Aymerich M
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():27-31. PubMed ID: 10605187
[TBL] [Abstract][Full Text] [Related]
19. Appropriate selection of antimicrobials in the treatment of ambulatory patients.
Goetz MB
Health Syst Lead; 1994 Oct; 1(8):34-8. PubMed ID: 10140124
[No Abstract] [Full Text] [Related]
20. [Antibiotics and health care economics].
Modai J; Droulers AM
Soins; 1981 Mar; 26(6):38-9. PubMed ID: 6910261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
